ÂÜÀòÂÒÂ×

Brian is a synthetic organic/medicinal chemist and has 20 years of drug discovery experience leading chemistry and project teams in both large pharma and biotech. He brings a broad range of experience across a number of therapeutic areas including neuroscience, oncology, infectious disease, and rare genetic disease. Most recently, Brian was the Head of Medicinal Chemistry at Epizyme. He also led the chemistry efforts for the rare genetic disease portfolio at Agios, for the respiratory syncytial virus (RSV) project at Enanta, and for many projects during his time at Johnson and Johnson (now Janssen). Brian earned his Ph.D. in organic chemistry from Duquesne University and received his postdoctoral training at the University of Rochester. He is a co-author on more than 25 scientific publications and an inventor on more than 35 issued patents and patent applications.